XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED AWARDS (Tables)
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of stock based compensation
Stock-based compensation expense was as follows (in thousands):
 
Three months ended
 September 30,
 
Nine months ended
 September 30,
 
2017
 
2016
 
2017
 
2016
Medici stock options
$
9

 
$

 
$
9

 
$

Restricted stock awards
1,015

 
1,390

 
3,000

 
4,105

Total stock-based compensation expense
$
1,024

 
$
1,390

 
$
3,009

 
$
4,105

Summary of restricted stock award activity
The following table summarizes restricted stock award activity during the nine months ended September 30, 2017 (in thousands):
 
Nine months ended
 September 30, 2017
 
Units
 
Weighted
Average
Grant Date
Fair Value
Outstanding—beginning of year
560

 
$
17.46

Granted at fair value
299

 
16.71

Vested
(202
)
 
19.82

Forfeited
(114
)
 
16.20

Outstanding—end of period
543

 
$
16.43